Vectibix User Reviews & Ratings
Vectibix has an average rating of 7.0 out of 10 from a total of 4 reviews on Drugs.com. 75% of reviewers reported a positive experience, while 25% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Colorectal Cancer | 4 reviews for Colorectal Cancer | 31 medications |
- Anonymous
- Taken for 1 to 6 months
- November 8, 2017
For Colorectal Cancer "This medication has my carcinoembryonic antigen (CEA) test numbers way down. I hate the rash, but at least I'm alive."
- Anonymous
- Taken for 1 to 6 months
- December 27, 2017
For Colorectal Cancer "Have been on this since 8-2017, and my CEA marker is down from 16.1 to 3.6. The side effect of dry skin is tolerable."
- Gle...
- March 29, 2016
For Colorectal Cancer "It's bad enough to have cancer, but this drug doesn't work and turns patients into lepers."
Are you taking this medicine?
Your review helps others make informed decisions.More about Vectibix (panitumumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
For Colorectal Cancer "Vectibix reduced my CEA (cancer marker) from 25.2 all the way down to 2.5 within the matter of a few months. The skin reaction sucks. Thankfully, I am able to undergo a revolutionary surgery to remove the portion of my liver with the metastatic cancer, so I have just recently been able to stop the Vectibix. I am hoping I will get my beautiful skin back."